ReNeuron touts promising results from stem cell trial

05/17/2013 | Bloomberg

Researchers are set to announce positive results from a trial of ReNeuron Group's stem cell treatment for the damage caused by stroke, CEO Michael Hunt said. The findings are expected to be presented this month at a conference in London. "It sets us up nicely for a Phase II efficacy trial," said Hunt.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC